CD8A and neoplasm: In conclusion, these experiments show that CD8 + immune responses from SLPs can be strongly enhanced by presenting the SLPs coupled to virosomes, using human cells in vitro, and virosomes presenting SLPs containing QS-21 adjuvant provide the best control of tumor outgrowth and improved survival in a mouse model.